Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells
- PMID: 8817470
- DOI: 10.1007/BF00225834
Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells
Abstract
The ability of ANP to inhibit the hydrolysis of phosphoinositides was examined in [3H] myoinositol-labeled intact murine Leydig tumor (MA-10) cells. Arginine vasopressin (AVP) stimulated the formation of inositol monophosphate (IP1), inositol bisphosphate (IP2), and inositol trisphosphate (IP3) both in a time-and dose-dependent manner in MA-10 cells. ANP inhibited the AVP-induced formation of IP1, IP2, and IP3 in these cells. The inhibitory effect of ANP on the AVP-stimulated formation of IP1, IP2, and IP3 accounted for 30%, 38% and 42%, respectively, which was observed at the varying concentrations of AVP. ANP caused a dose-dependent attenuation in AVP-stimulated production of IP1, IP2 and IP3 with maximum inhibition at 100 nM concentration of ANP. The production of inositol phosphates was inhibited in the presence of 8-bromo cGMP in a dose-dependent manner, whereas dibutyryl-cAMP had no effect on the generation of these metabolites. The LY 83583, an inhibitor of guanylyl cyclase and cGMP production, abolished the inhibitory effect of ANP on the AVP-stimulated production of inositol phosphates. Furthermore, 10 microM LY 83583 also inhibited the ANP-stimulated guanylyl cyclase activity and the intracellular accumulation of cGMP by more than 65-70%. The inhibition of cGMP-dependent protein kinase by H-8, significantly restored the levels of AVP-stimulated inositol phosphates in the presence of either ANP or exogenous 8-bromo cGMP. The results of this study suggest that ANP exerts an inhibitory effect on the production of inositol phosphates in murine Leydig tumor (MA-10) cells by mechanisms involving cGMP and cGMP-dependent protein kinase.
Similar articles
-
Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.Front Mol Neurosci. 2014 Aug 22;7:75. doi: 10.3389/fnmol.2014.00075. eCollection 2014. Front Mol Neurosci. 2014. PMID: 25202235 Free PMC article. Review.
-
Stimulation of atrial natriuretic peptide receptor/guanylyl cyclase- A signaling pathway antagonizes the activation of protein kinase C-alpha in murine Leydig cells.Biochim Biophys Acta. 1997 Apr 24;1356(2):221-8. doi: 10.1016/s0167-4889(96)00168-1. Biochim Biophys Acta. 1997. PMID: 9150279
-
Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.Endocrinology. 1988 Apr;122(4):1478-85. doi: 10.1210/endo-122-4-1478. Endocrinology. 1988. PMID: 2894298
-
Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2629-38. Invest Ophthalmol Vis Sci. 1997. PMID: 9375582
-
Putative role of inositol phospholipid metabolism in neurons.Biochimie. 1987 Apr;69(4):287-96. doi: 10.1016/0300-9084(87)90019-8. Biochimie. 1987. PMID: 2820514 Review.
Cited by
-
Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells.Mol Cell Biochem. 2002 Apr;233(1-2):165-73. doi: 10.1023/a:1015882302796. Mol Cell Biochem. 2002. PMID: 12083372
-
Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.Can J Physiol Pharmacol. 2011 Aug;89(8):557-73. doi: 10.1139/y11-054. Epub 2011 Aug 4. Can J Physiol Pharmacol. 2011. PMID: 21815745 Free PMC article. Review.
-
Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.Front Mol Neurosci. 2014 Aug 22;7:75. doi: 10.3389/fnmol.2014.00075. eCollection 2014. Front Mol Neurosci. 2014. PMID: 25202235 Free PMC article. Review.
-
Functional silencing of guanylyl cyclase/natriuretic peptide receptor-A by microRNA interference: analysis of receptor endocytosis.Int J Biochem Mol Biol. 2013 Mar 31;4(1):41-53. Print 2013. Int J Biochem Mol Biol. 2013. PMID: 23638320 Free PMC article.
-
Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics.Front Mol Neurosci. 2023 Jan 4;15:1076799. doi: 10.3389/fnmol.2022.1076799. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36683859 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous